2016 wrap-up
What a rollercoaster. On the good side, we've seen advances in sequencing methods including improvements in Nanopore sequencing and single cell methods becoming more common. We also saw 10x genomics come to the party with an emulsion PCR approach that can be applied to produce synthetic long reads or single cell barcoding. There were major results from larger cohort studies exemplified by ExAC , which is revealing more about human genetic variation, while Blueprint and GTEx are revealing more about determinants of gene regulation. The #openaccess is growing rapidly in the bioinformatics community, along with the growth of preprint popularity which I hope is adopted more widely in the biomedical sciences. On the not so good side, Illumina has made made no new instrument announcements nor any substantial updates to existing sequencing systems. There were a few papers ( example ) describing the methylation EPIC array announced in 2015. Prices for Illumina reagents continue t